Nature Communications (Oct 2020)

Type 2 and interferon inflammation regulate SARS-CoV-2 entry factor expression in the airway epithelium

  • Satria P. Sajuthi,
  • Peter DeFord,
  • Yingchun Li,
  • Nathan D. Jackson,
  • Michael T. Montgomery,
  • Jamie L. Everman,
  • Cydney L. Rios,
  • Elmar Pruesse,
  • James D. Nolin,
  • Elizabeth G. Plender,
  • Michael E. Wechsler,
  • Angel C. Y. Mak,
  • Celeste Eng,
  • Sandra Salazar,
  • Vivian Medina,
  • Eric M. Wohlford,
  • Scott Huntsman,
  • Deborah A. Nickerson,
  • Soren Germer,
  • Michael C. Zody,
  • Gonçalo Abecasis,
  • Hyun Min Kang,
  • Kenneth M. Rice,
  • Rajesh Kumar,
  • Sam Oh,
  • Jose Rodriguez-Santana,
  • Esteban G. Burchard,
  • Max A. Seibold

DOI
https://doi.org/10.1038/s41467-020-18781-2
Journal volume & issue
Vol. 11, no. 1
pp. 1 – 18

Abstract

Read online

ACE2 and TMPRSS2 have received recent attention as entry factors for SARS-CoV-2. Here the authors analyze nasal airway transcriptome data from 695 children determining ACE2 and TMPRSS2 expression is induced by viral and type2 inflammation, respectively, and both exhibit eQTLs that vary across world populations.